Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema (Q64044928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

title

Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

main subject

hereditary angioedema

0 references

prophylaxis

0 references

author name string

H Henry Li

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

Marc Riedl

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

Jay Kashkin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

English

0 references

publication date

1 April 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

Clinical Reviews in Allergy & Immunology

31 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

207-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

31 March 2020

copyright license

start time

16 June 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema--evidence of a functionally critical level of C1-inhibitor concentration

1 reference

12 December 2020

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

1 reference

12 December 2020

Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency

1 reference

12 December 2020

BIOLOGICAL ACTIVITIES OF C1 INHIBITOR

1 reference

12 December 2020

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

1 reference

12 December 2020

The bradykinin-forming cascade and its role in hereditary angioedema

1 reference

12 December 2020

HAE international home therapy consensus document.

1 reference

12 December 2020

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema

1 reference

12 December 2020

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.

1 reference

12 December 2020

Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives

1 reference

12 December 2020

Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study

1 reference

12 December 2020

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study

1 reference

12 December 2020

Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

1 reference

12 December 2020

Cinryze&trade; as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety

1 reference

12 December 2020

Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema

1 reference

12 December 2020

Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks

1 reference

12 December 2020

Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits

1 reference

12 December 2020

Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey

1 reference

12 December 2020

C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies

1 reference

12 December 2020

Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children

1 reference

12 December 2020

Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain.

1 reference

12 December 2020

A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema

1 reference

12 December 2020

Risk of angioedema following invasive or surgical procedures in HAE type I and II--the natural history

1 reference

12 December 2020

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study

1 reference

12 December 2020

The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe.

1 reference

12 December 2020

Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema

1 reference

12 December 2020

Depression and anxiety in patients with hereditary angioedema

1 reference

12 December 2020

Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial

1 reference

12 December 2020

US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency.

1 reference

12 December 2020

Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema

1 reference

12 December 2020

The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study

1 reference

12 December 2020

Canadian hereditary angioedema guideline

1 reference

12 December 2020

Safety of C1-esterase inhibitor in acute and prophylactic therapy of hereditary angioedema: findings from the ongoing international Berinert patient registry

1 reference

12 December 2020

Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema.

1 reference

12 December 2020

Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals

1 reference

12 December 2020

Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema

1 reference

12 December 2020

Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent

1 reference

12 December 2020

Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data

1 reference

12 December 2020

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.

1 reference

12 December 2020

Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance

1 reference

12 December 2020

Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility.

1 reference

12 December 2020

Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry

1 reference

12 December 2020

Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients

1 reference

12 December 2020

Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor

1 reference

12 December 2020

Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings

1 reference

12 December 2020

Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States

1 reference

12 December 2020

Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade

1 reference

12 December 2020

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial

1 reference

12 December 2020

The international WAO/EAACI guideline for the management of hereditary angioedema - the 2017 revision and update

1 reference

12 December 2020

Hereditary Angioedema: The Economics of Treatment of an Orphan Disease

1 reference

12 December 2020

10.1007/S12016-018-8684-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29909591 AND SRC:MED&resulttype=core&format=json

31 March 2020

1 reference